LobbyingHackensack Meridian Health lobbying by quarter
Hackensack Meridian Health's latest lobbying report covers Q2 2026, at $340K. The four quarters Q3 2025–Q2 2026 total $1.4M. Its first report covers Q3 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Hackensack Meridian Health
- Latest quarter
- $340K
- Q2 2026 · 4 reports
- Last 12 months
- $1.4M
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q3 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2022 | $37K | 1 |
| Q4 2022 | $297K | 5 |
| Q1 2023 | $297K | 5 |
| Q2 2023 | $297K | 5 |
| Q3 2023 | $297K | 5 |
| Q4 2023 | $317K | 5 |
| Q1 2024 | $277K | 6 |
| Q2 2024 | $327K | 5 |
| Q3 2024 | $317K | 5 |
| Q4 2024 | $317K | 5 |
| Q1 2025 | $357K | 6 |
| Q2 2025 | $340K | 6 |
| Q3 2025 | $340K | 4 |
| Q4 2025 | $340K | 4 |
| Q1 2026 | $340K | 4 |
| Q2 2026 | $340K | 4 |
Policy issues the reports name
- Health issues54 reports
- Medicare and Medicaid50 reports
- Budget and appropriations27 reports
- Education12 reports
- Medical research and clinical labs9 reports
- Science and technology6 reports
- Pharmacy2 reports
- Taxation1 reports
- Immigration1 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES62 reports
- SENATE61 reports
- Centers For Medicare and Medicaid Services (CMS)29 reports
- Health & Human Services, Dept of (HHS)13 reports
- White House Office11 reports
- Health Resources & Services Administration (HRSA)9 reports
- Natl Institutes of Health (NIH)3 reports
- Office of Science & Technology Policy (OSTP)3 reports
- Federal Emergency Management Agency (FEMA)2 reports
- Office of Natl Drug Control Policy (NDCP)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseHackensack Meridian Health | $2.6M | 15 quarters |
| Impact Health Policy Partners | $660K | 15 quarters |
| DB3 | $560K | 10 quarters |
| Strategic Health Care | $407K | 12 quarters |
| Baker Donelson Bearman Caldwell & Berkowitz | $300K | 6 quarters |
| Welsh Rose | $280K | 6 quarters |
| Hooper, Lundy & Bookman, P.C. | $30K | 11 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| THOMAS DASCHLE | Former United States Senator | Q2 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | DB3 | $60K |
| 07/08for Q2 | Welsh Rose | $50K |
| 07/07for Q2 | In-house | $180K |
| 07/06for Q2 | Impact Health Policy Partners | $50K |
| 04/20for Q1 | DB3 | $60K |
| 04/10for Q1 | Impact Health Policy Partners | $50K |
| 04/08for Q1 | Welsh Rose | $50K |
| 04/08for Q1 | In-house | $180K |
| 01/20for Q4 2025 | DB3 | $60K |
| 01/16for Q4 2025 | Welsh Rose | $50K |
| 01/13for Q4 2025 | Impact Health Policy Partners | $50K |
| 01/06for Q4 2025 | In-house | $180K |
| 25/10/20for Q3 2025 | DB3 | $60K |
| 25/10/20for Q3 2025 | Welsh Rose | $50K |
| 25/10/13for Q3 2025 | Impact Health Policy Partners | $50K |
| 25/10/10for Q3 2025 | In-house | $180K |
| 25/07/18for Q2 2025 | Hooper, Lundy & Bookman, P.C. | Under $5,000 |
| 25/07/18for Q2 2025 | DB3 | $60K |
| 25/07/16for Q2 2025 | Impact Health Policy Partners | $50K |
| 25/07/10for Q2 2025 | Strategic Health Care | Under $5,000 |